MENU
QNTM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Quantum Biopharma (QNTM) Ownership - Who owns Quantum Biopharma?
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
56.37M
P/E Ratio
N/A
Total Cash
3.54M
Projected Growth
N/A
Total Debt
1.28M
Revenue
N/A
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash/Share
1.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
QNTM
Capitalization
56.4M
P/E Ratio
N/A
Risk (Beta)
0.48
Dividend Yield
N/A
Total Cash
3.54M
Total Cash/Share
1.22
Total Debt
1.28M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
5.73M
P/B Ratio
9.99
Cash Flow
N/A
Earnings
-13.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
153M
Current Ratio
0.96
Current Revenue Per Employee
8844.20
Dividends Per Share - Security
N/A
EBITDA
-20.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
-631.42
Revenue To Assets
-137.74
Shares Held By Institutions
1.09M
Shares Outstanding - Current
2.91M
Total Liabilities
10.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
435.054
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the production and processing of hydroponic indoor cannabis.
Industry Biotechnology
Profile
Fundamentals
Details